发明申请
US20090176851A1 Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1
审中-公开
螺旋[咪唑烷-4,3' - 内酰胺] 2,2'，5'（1H）二恶烷用于治疗与香草素受体1相关的病症的用途
![Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1](/docs/US/2009-07-09/US20090176851A1/abs.jpg.600x600.jpg)
- 专利标题： Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1
- 专利标题（中）： 螺旋[咪唑烷-4,3' - 内酰胺] 2,2'，5'（1H）二恶烷用于治疗与香草素受体1相关的病症的用途
-
申请号： US12278657申请日： 2007-02-06
-
公开(公告)号： US20090176851A1公开(公告)日： 2009-07-09
- 发明人: Lucy Horoszok , Carmen Leung , Miroslaw Tomaszewski , Christopher Walpole
- 申请人： Lucy Horoszok , Carmen Leung , Miroslaw Tomaszewski , Christopher Walpole
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 国际申请： PCT/SE2007/000106 WO 20070206
- 主分类号： A61K31/4188
- IPC分类号： A61K31/4188 ; C07D487/10 ; A61P25/00 ; C07D209/38
![Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1](/abs-image/US/2009/07/09/US20090176851A1/abs.jpg.150x150.jpg)
摘要：
The present invention relates to a new use of spiro-hydantoin derivatives of formula (I), or salts, solvates or solvated salts thereof, as well as to new compounds, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy.
信息查询
IPC分类:
